Cibus Inc CBUS

$1.71 +0.08 (4.91%)

Valuation

Market cap: 124,579,000
Revenue TTM: $3,640,000
Net income TTM: $-127,090,000
PE ratio: 0.00
Forward PE: —
Profit margin: -3,491.48%
Debt to equity: 0.00

Trading

Volume: 247,400
Avg volume: 135,808
Day's range: $1.63 – $1.76
Shares out: 76,429,000
Stochastic %K: 89%
Beta: 1.57
Analysts: Sell
Price target: $13.50

Price

Company profile

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 858 450 0008
Website: https://www.cibus.com
Address: 6455 Nancy Ridge Drive, San Diego, United States